- Cogstate’s global partner Eisai enters a deal with FCNT aiming to prevent dementia and support people living with the syndrome in Japan.
- Under this business alliance, Eisai developed a self-checking tool of brain performance, known as NouKNOW is to be installed on “Raku Raku Smartphone”.
- The “Raku Raku Smartphone F-52B” will be equipped with the digital tool for self-examination of brain performance “NouKNOW”, distributed by Eisai.
ASX-listed Company involved in manufacturing and distribution of diagnostic and therapeutic products associated with neurological disorder Cogstate Limited (ASX:CGS) shared on Monday that Cogstate technology will be marketed in Japan as a pre-installed application on a smartphone used widely by the senior population.
The announcement revealed that from February 2022, the Raku-Raku smartphone will be shipped with a self-checking tool of brain performance, known as NouKNOW, pre-installed on the device. The Raku-Raku smartphone is marketed to the senior population in Japan and has shipped more than 7 million units. NouKNOW is a tool for self-examination of brain health based upon technology built by Cogstate, which utilises a selection of cognitive assessments collectively known as the “Cogstate Brief Battery”. The Japanese product launch of NouKNOW occurred on 31 March 2020.
The Company revealed that its global commercial partner Eisai Co., Ltd has entered into a business alliance agreement with FCNT Limited aiming to prevent dementia and support people living with this syndrome.
Under the agreement, both companies will construct an ecosystem with the aim of supporting people living with and preventing dementia, by integrating Eisai's specialisation, including drug creation and disease awareness exercises and Eisai's solution measures like digital technology, in the area of dementia, and FCNT's products like smartphones designed to provide remarkable usability for the old and FCNT's services including "Raku Raku Community".
Eisai and FCNT will address and solve the social issue related to dementia and promote co-creation of value toward achieving a healthy and long-lived society by contributing to the construction of a “Dementia Ecosystem” by merging the strengths of both companies.